NFH
VKTX icon

NEXT Financial Holdings’s Viking Therapeutics VKTX Stock Holding History

NEXT Financial Holdings’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$7K Buy
+700
New +$5.86K ﹤0.01% 1199

Other funds holding VKTX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $29.2B AUM 20.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NEXT Financial Holdings's VKTX Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Viking Therapeutics (VKTX) in Q1 2019: 700 shares worth $7K. The stake represents ﹤0.01% of the portfolio and ranks #1199 among its holdings.

164 funds tracked by Wall St. Rank hold VKTX as of Q1 2019.

  • NEXT Financial Holdings held 700 shares of Viking Therapeutics worth $7K as of Q1 2019.
  • Viking Therapeutics was a new NEXT Financial Holdings position in Q1 2019.
  • Viking Therapeutics made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1199 holding.
  • 164 funds tracked by Wall St. Rank held Viking Therapeutics as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.